WGB Stock Overview
Operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Integer Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$126.00 |
| 52 Week High | US$129.00 |
| 52 Week Low | US$78.50 |
| Beta | 1.09 |
| 11 Month Change | 6.78% |
| 3 Month Change | 15.60% |
| 1 Year Change | 54.60% |
| 33 Year Change | 61.54% |
| 5 Year Change | 89.47% |
| Change since IPO | 412.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| WGB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | -0.5% |
| 1Y | 54.6% | -4.2% | 8.3% |
Return vs Industry: WGB exceeded the German Medical Equipment industry which returned -4.2% over the past year.
Return vs Market: WGB exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| WGB volatility | |
|---|---|
| WGB Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: WGB has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: WGB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 10,500 | Joe Dziedzic | www.integer.net |
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Integer Holdings Corporation Fundamentals Summary
| WGB fundamental statistics | |
|---|---|
| Market cap | €4.24b |
| Earnings (TTM) | €110.57m |
| Revenue (TTM) | €1.63b |
38.4x
P/E Ratio2.6x
P/S RatioIs WGB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WGB income statement (TTM) | |
|---|---|
| Revenue | US$1.71b |
| Cost of Revenue | US$1.25b |
| Gross Profit | US$462.36m |
| Other Expenses | US$345.96m |
| Earnings | US$116.40m |
Last Reported Earnings
Sep 27, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.47 |
| Gross Margin | 27.00% |
| Net Profit Margin | 6.80% |
| Debt/Equity Ratio | 66.6% |
How did WGB perform over the long term?
See historical performance and comparison